Preprint
Article

Knowledge and Misinformation about Breast cancer risk factors, symptoms, and prevention among healthy and affected women: a study on 2,375 Italian participants

Altmetrics

Downloads

133

Views

80

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

24 August 2024

Posted:

27 August 2024

You are already at the latest version

Alerts
Abstract
Background: Breast cancer is the most common cancer among women worldwide and remains the leading cause of death among Italian women. Despite increased breast cancer awareness and improved diagnostic techniques, mortality rates remains high globally. In Italy, despite the availability of screening programs by the National Health System (NHS) for all Italian women aged 50-69 every two years, the participation rate remains relatively low. The low uptake of screening may be attributed to a lack of general cancer knowledge among women, including awareness of risk factors, symptoms, and prevention measures. This study investigates the knowledge and misinformation in a population of Italian women regarding breast cancer risk factors, symptoms, and prevention. Methods: From March 2021 to January 2022, we conducted a survey targeting the female population in Italy, with a total of 2375 participants willingly participating in the study. To investigate factors linked to variations in attitudes toward breast cancer, the participants were categorized into two groups: the general population (Group A, n=2235) and women who have had or currently have breast cancer (Group B, n=140). Statistically significant differences were identified between these two groups. Results: The findings revealed considerable confusion regarding both the symptoms and causes associated with cancer, as well as prevention measures. This confusion was particularly prominent among women in the general population and those with lower levels of education. Conclusions: Given these insights, it remains crucial to promote accurate health information concerning risk factors, symptoms, and prevention strategies related to this devastating disease, emphasizing the ongoing importance of disseminating correct health information.
Keywords: 
Subject: Public Health and Healthcare  -   Public Health and Health Services

Introduction

Breast cancer represents the most common form of cancer worldwide [1,2] with 55,700 new diagnoses and 12,500 deaths expected in Italy in 2022 [3]. Despite increased awareness and public attention, breast cancer mortality rates remain high globally and continue to be the leading cause of death in Italy [3]. Improved diagnostic techniques have enabled early detection, allowing for the identification of small tumors that may not be easily detectable. Early intervention is crucial in planning a treatment and/or surgery for neoplasms at an early stage. Thus, early diagnosis remains the most vital factor in improving patient prognosis, with prevention and adherence to screening programs being the most effective strategies. Mammography screening is a periodic secondary prevention measure aimed at women, enabling the earliest possible diagnosis of breast cancer. This approach facilitates less aggressive and more effective treatments, ultimately reducing mortality from this devastating disease [3]. In Italy, in line with the prevention guidelines, mammography screenings are provided free of charge every two years to women aged 50-69 [3]. It has been observed that mortality reduction for women in this age group is estimated at 23% for both adherent and non-adherent individuals, while women adherent to screening experience a 40% reduction. However, this opportunity is not always utilized, and significant geographical disparities have been observed in terms of screening program implementation, breast cancer incidence, and survival rates [4,5]. Lack of knowledge regarding risk factors, symptoms, and prevention strategies for cancer may underlie the low adherence to screening programs. For instance, results from a European and Italian survey indicate inadequate awareness in Italy regarding the conscious approach to screening examinations [6,7]. Extensive studies conducted in recent years have revealed that 20-30% of newly diagnosed breast cancer cases are associated with various risk factors that actively initiate or modify the neoplastic transformation of breast cells [3,8,9,10,11,12,13]. Age at first birth [3], genetic factors, endocrine influences, diet, environmental factors, lifestyle, and previous breast conditions are all linked to the risk of developing breast cancer. Notably, advancing age increases the risk due to endocrine proliferative stimuli and the accumulation of genetic transcription errors in cellular DNA [3]. Hormonal factors such as early menarche, late menopause, and hormone therapy use play a role [10]. Genetic predisposition [14], including alterations in the BRCA-1 and BRCA-2 genes, carries lifetime risks of 65% and 40% for developing breast cancer, respectively [3]. Personal history of breast cancer or specific noncancerous breast diseases , as well as a history of ovarian, endometrial, or colon cancer, which increases the risk of developing breast cancer by 1-2 times, are also relevant factors. Lifestyle parameters affected by factors such as obesity [15,16], diet [17,18,19], excessive alcohol consumption, smoking, stress [9], and pollution [8] contribute to the risk as well [20]. Therefore, mammography, and other medical imaging [21,22,23], plays a crucial role in cases where early symptoms of breast cancer, such as palpable lumps, are present. Another prevention method that is highly debated but strongly recommended is Breast Self-Examination (BSE) [24,25]. BSE involves periodic self-palpation of the breasts by women to identify any changes that should be reported to their healthcare provider. While self-examination alone is not sufficient in an age where mammography and breast ultrasound can detect tumors as small as a few millimeters, it should be noted that when performed correctly and regularly, this technique can help reduce the risk of diagnosing advanced breast cancer. Moreover, self-examination is a convenient and cost-effective method that women can start from the age of 20 [26]. Educating women about the benefits of self-examination is crucial, as it is the easiest and most accessible way to detect breast cancer at an early stage [26].
Therefore, prevention is essential, but equally important is knowledge about cancer. The more people are aware of the risk factors and symptoms of breast cancer, the more likely they are to approach screening positively. Against this backdrop, the objective of this study is to investigate the knowledge and misconceptions regarding breast cancer among Italian women, focusing on risk factors, symptoms, and prevention.

Methods

General Study Details

Between March 2021 and January 2022, a survey was undertaken targeting the female population in Italy. A total of 2375 participants voluntarily participated in the study by completing an anonymous questionnaire. The survey, distributed on a voluntary basis, was conducted exclusively among Italian women aged 20 to 69 who provided informed consent. As this study was survey-based and the questionnaire was sent to women who voluntarily responded, approval from the institutional ethics committee was not sought.

Participants

Exclusion criteria involved non-compliance with the age range or lacking Italian citizenship. The questionnaire was digitally implemented using a predefined form on the Google Forms platform, and the study employed electronic means for disseminating the questionnaire. Outreach efforts involved contacting various Facebook groups and Instagram pages that featured computerized questionnaires.

Aim

The questionnaire was administered to assess the knowledge and misinformation in a population of Italian women concerning risk factors, symptoms, and prevention of Breast Cancer.

Study Methodology

The predesigned, not pretested questionnaire was expected to take approximately 10 minutes to complete. Socio-demographic data such as age, geographical area of residence, marital status, level of education, and employment status were collected. The administered questionnaire consisted of 43 items divided into two sections. The first section (11 items) focused on knowledge and beliefs about the causes and symptomatology of breast cancer. The second section (32 items) assessed knowledge and beliefs about breast cancer prevention. The questionnaire was sent trough social network. The sampling approach employed virtual snowball sampling until data saturation was achieved. An unanswered questionnaire is attaches as Supplementary appendix 1.

Ethical Considerations

The ethical considerations of the study were explicitly outlined during the presentation of the questionnaire. The design of the questionnaire adhered to the principles established by the Italian data protection authority (DPA). The study was approved by Bioethical Committee of IRCCS, Bari, under protocol number 1695/CEL dated 10/06/2024 conducted according to ethical guidelines established by the Declaration of Helsinki and other guidelines like Good Clinical Practice Guidelines. Emphasis was placed on the voluntary nature of participation, with participants retaining the right to decline involvement in the protocol at any point. Individuals expressing interest in participating were provided with an informed consent form that reiterated the voluntary nature of participation and underscored the confidentiality and anonymity of the shared information. To uphold anonymity, the responses of participants were deidentified.

Definition

The term "general population" refers to the entire set of individuals or people within a specified geographic area or community who share common characteristics or attributes. This group typically represents a broad and diverse cross-section of society, encompassing people of various demographics, ages, backgrounds, and lifestyles. In research and surveys, the general population serves as the target group from which researchers draw samples to make inferences about broader trends, attitudes, behaviors, or characteristics. It contrasts with specific subpopulations, which may be defined by certain criteria such as age, gender, ethnicity, or other factors.
"Women with a history of breast cancer" refers to individuals of the female gender who have been previously diagnosed and treated for breast cancer. This term encompasses women who have undergone medical interventions, such as surgery, radiation therapy, chemotherapy, or a combination of these, to address the presence of breast cancer in their medical history. The phrase is often used in medical and research contexts to categorize a specific subgroup of individuals for the purpose of studying or addressing issues related to breast cancer survivorship, treatment outcomes, and long-term health considerations.

Statistics

Descriptive statistics were employed to report the questionnaire responses from all participants. To pinpoint items linked to variations in breast cancer-related behavior, the subjects were categorized into two groups: the general population (Group A, n = 2235) and women with a history of breast cancer (Group B, n = 140). For each question, respondents were further stratified by age, educational level, geographic area, and marital status, as applicable. Continuous variables were summarized using the mean and standard deviation (SD), while categorical variables were presented with frequencies and percentages. Group differences were assessed using the Mann-Whitney U-test, considering a p-value <0.05 as statistically significant. All statistical analyses, encompassing both qualitative and quantitative variables, were performed using MATLAB software.

Results

The questionnaire was delivered to 2250 eligible women. Complete responses were received from a total of 2235 (99%) and included in the final analysis (Figure 1).
Baseline characteristics were assessed for all participants, and the data are summarized in Table 1. To explore potential differences in women's information, knowledge, and beliefs regarding breast cancer, the respondents were divided into two groups: Group A, which includes women who have not been diagnosed with breast cancer (94%, n=2235, referred to as the "general population"), and Group B, which includes women who have already been diagnosed with breast cancer (6%, n=140).
Section 1 of Table 2 specifically investigates respondents' knowledge of causes and symptomatology associated with cancer. As expected, women in the general population report were less informed than women with prior cancer (56% vs. "93%" for the cumulated "very" and "fairly" answers, respectively), p<0.05. It would also appear that this lack of knowledge on the topic is correlated with age: almost half (48%) of the women in the general population who say they are poorly informed are mainly in the 20-30 age group. Level of education also seems to affect this trend as women in Group A with no or very low level of education admit to knowing little about the disease (data not shown).
Going into detail about the knowledge they possessed, respondents were asked whether they considered endocrine factors, previous breast disease, diet, pollution, and psychological stress to be possible causes of breast cancer occurrence. Although it is now known that higher-than-normal levels of sex hormones, estrogens and androgens, can promote the occurrence of heredo-familial cancers such as breast or prostate cancer, there are many women who deny this relationship. Surprisingly, it is mostly women with previous cancer compared to others who exclude endocrine involvement among the causes of cancer (29% vs 17%, respectively), p<0.001. Level of education also affects the responses, considering that half of the women in the general population (50%) who deny such endocrine involvement have no level of education (data not shown).
Breast cancer is believed to have a strong familial predisposition. Of course, not all breast pathologies lead to heritable cancers, and not all breast pathologies affect the occurrence of cancer in the same woman who had previous pathologies. When asked whether previous breast disease affected the occurrence of breast cancer, women in both groups gave affirmative responses (95% vs. 88% Group A and Group B, respectively), p<0.01. Again, level of education affects the responses, given that women who tended to deny a relationship between previous breast disease and cancer either lacked education (50%) or possessed only a junior high school diploma (57% and 67% Group A and Group B, respectively) (data not shown).
Nutrition is another highly debated factor between the two groups of respondents (p<0.001). The combination of diet and cancer occurrence is often the focus of media attention from doctors and nutritionists. Incredibly, less than half (49%) of women in the general population and only 67% of women with prior cancer know the importance of diet in cancer. Especially young women under the age of 30 (57%) and with low levels of schooling (67%) deny this relationship (data not shown).
Another sustained cause of cancer involves pollution and environmental factors. Although there are many people who consider pollution to be among the leading causes of cancer, in fact, at present, this association is highly debated in the scientific field. Women with previous cancer more frequently replied “yes”, if compared with Group B (71% vs. 48%).
Lastly, psychological stress. Remarkably, the majority of women with previous cancer (71%) consider psychological stress to be a key factor in cancer occurrence (p=0.01).
The following questions address knowledge about breast cancer symptomatology, specifically women were asked whether breast pain (mastodynia), the presence of palpable lumps, breast shape/size change, and nipple alteration/secretion were symptoms associated with cancer.
Mastodynia is not one of the symptoms found in this disease unless tissue inflammation is also present (33), which occurs in only 5% of cases (34). Women in the general population prove to be more uninformed about this aspect, collecting 59% of "yes" responses in contrast to 33% of affirmative responses from women with previous cancer. The majority of "yes" votes in Group A were for women under 30 years of age and without any level of education (75%) (data not shown), again demonstrating that age and level of education affect cancer knowledge. In contrast to breast pain, the presence of a palpable lump may instead be an indication of breast cancer. Women with a history of previous cancer, understandably, exhibit greater awareness of this condition, with 83% of responses indicating familiarity. However, it is more concerning that in the remaining 17% of cases, respondents do not possess this knowledge. Age and level of education correlate with "no," garnering more very young women under the age of 30 (38%) and with low levels of schooling (100%). Interestingly, the majority of women who deny the presence of a palpable lump as the start of breast cancer are from the South and the islands (data not shown).
Both groups at 71% count change in breast shape and size and nipple alteration/secretion among the possible symptoms of breast cancer. These are actually no symptoms specifically attributable to the cancer, although these phenomena happen more often in very old patients. Nevertheless, all women under the age of 30 (100%) considered nipple secretion to be a present symptom.
In section 2, possible misinformation was also investigated in the area of prevention. Women were asked whether they were well informed and whether they thought it would be useful to have some of the most common clinical checkups, such as clinical palpation, ultrasound, mammography, and other tests such as blood tests and diagnostic imaging. Although almost all women knew the meaning of prevention – understood as prevention of risk factors and early diagnosis – it is serious to note that nearly half (47%) of the women in the general population said they knew little or nothing at all about prevention itself, and among them, all have no level of education.
Clinical palpation, mammography, and ultrasound were considered useful as screening tests by almost all women. Schooling proves to be a crucial factor for misinformation in this area, considering that 67% of women with prior cancer and 50% of women in the general population who did not find clinical palpation and ultrasound useful possessed a primary school diploma (data not shown). Surprisingly, a notable number of women are unfamiliar with the concept of a mammogram (n= 131, 7% in Group A and 22.2% in Group B).
In Italy, mammography is indicated in women 40 years of age and older and is offered free of charge by the National Health System (NHS) to women over 50 and up to 69 years of age. It is not normally indicated under 30 years of age. The responses were very different in the two groups (A and B) and the difference is statistically significant (p<0.05). Incredibly, only 31% of women with cancer thought it was correct to have mammography in the 40-50 range and even worse, no women with previous cancer (0%) thought it was correct to have this examination in the 50-69 range, the only period covered by free screening in Italy.
Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) are normally never prescribed as screening tests, except in cases of young women with pronounced genetic familiarity and cases of known staging, respectively. The standard goal for breast cancer diagnosis is certainly biopsy, but even this is not to be counted among the screening tests for preventive purposes. Still, more than 20% in both groups considered these tests useful, although many of these respondents did not have any level of education (data not shown).
Blood tests are also not useful for breast cancer diagnosis. Yet, strangely, 34% of women with cancer considered them useful, and this %age rises in the group of women in the general population (52%), (p<0.001). Again, most of the women under the age of 30 or without any level of education thought blood test were useful. Similarly, as concerns the intervention of the oncologist. The oncologist is the reference figure in the case of established diagnosis, and normally does not intervene in the screening phase. In contrast, 35% of women with cancer considered that talking to the oncologist can be useful, a percentage that rises to 45% in the case of women in the general population, (p<0.01).
In the remaining part of the questionnaire, the survey explores knowledge on the topic of self-palpation. Almost all women in both groups said they had heard of self-palpation (97 % Group A and 98 % Group B) and most of them knew the meaning of the term (82 % Group A and 87 % Group B), with the exception of a group of very young women under 30 or those with no or low levels of schooling (data not shown). The percentages, however, drop dramatically when it comes to how much self-examination can help in cancer prevention: surprisingly, less than half (41%) of women in Group A and just over half (56%) of women in Group B strongly agreed that it is a valuable aid, and the women who describe themselves as uncertain tend to be those with low levels of education (data not shown). While self-palpation was also considered an important tool for periodic monitoring even following breast examination and/or mammography, neither group of women responded unanimously, with some even expressing uncertainty about this, especially among women with previous cancer (p<0.05). There is disagreement regarding the effectiveness of self-palpation for the reduction of mortality: self-palpation is a self-diagnosis tool that could aid in detecting palpable nodules, thus enabling early intervention and diagnosis. Regular self-examination, in addition, could serve to find a breast lump early, which would mean early intervention to limit the consequences of cancer. Therefore, it is crucial to diagnose the disease as early as possible to reduce mortality. Despite this well-known evidence, many women disagreed on the issue in both groups (p<0.05), and many expressed uncertainty, even among the group with previous cancer (23%). A significant number of them, however, have no educational level or only a primary diploma (data not shown). Among the two groups surveyed, women with cancer were in general more aware (p<0.05), but a large proportion of uncertain women were nonetheless present (24% Group A and 19% Group B).

Discussion

The aim of the study was to investigate women's knowledge and misinformation about breast cancer. Specifically, the information possessed by the respondents was divided into several sections. Section 1 investigated the knowledge possessed about the causes and possible signs and symptoms associated with cancer; section 2 investigated the topic of prevention, understood as the perception of the usefulness of some common diagnostic tests such as clinical palpation, ultrasound, mammography, biopsy, and others such as blood tests and diagnostic imaging (MRI and CT) in preventing breast cancer; The knowledge regarding self-palpation as an important tool for periodic monitoring of breast changes were also investigated. In order to ascertain any difference in information possession, women were divided into two groups: Group A including women who had not been diagnosed with breast cancer and Group B including women who had already been diagnosed with breast cancer.
Analysis of the above data shows that almost half of Group-A women admitted to have little knowledge about cancer, unlike women with previous cancer, who – as expected – reported being more informed, and this is in line with data obtained from a cross-sectional survey conducted in 5 European countries including Italy [6]. This is a significant finding that draws attention to the need to increase health information. Indeed, a great deal of misinformation has emerged regarding the role of endocrine factors, the presence of previous breast disease, nutrition, pollution, and psychological stress as possible risk factors for the onset of breast cancer. Although over the past two decades the involvement of endocrine factors in the occurrence of heredo-familial cancers has been well established, and the concept of nutritional support as part of a comprehensive cancer management program has gained increasing [10,11,12,13,27], there were many women who denied such correlations with cancer. While diet as a modulable factor for cancer prevention is often the focus of media attention, the relationship between environmental pollution and the occurrence of breast cancer is currently highly debated in the medical-scientific arena. There were many women interviewed who supported this pairing, especially those who had the disease in the past. In fact, there are no conclusive studies, although some observations suggest a hypothetical increase in exposed women [8,16]. Psychological stress is also considered as a probable cause of cancer [14], in line with some recent studies, [28,29] in which a high level of perceived stress has been shown to be among the modifiable risk factors.
Much misinformation has also been observed about the symptomatology with which the tumor might present itself, in line with other studies in the literature [30,31,32]. Generally, in its early stages, the disease does not give rise to specific symptoms. Despite this, there are a large number of women, from Group B, who found breast pain, nipple alteration/secretion, and change in shape and size to be among the detectable symptoms. In contrast to these almost always non-evident signs, the presence instead of a palpable lump may be indicative of breast cancer. Even on the subject of prevention, the women interviewed admitted to have strong misinformation. A systematic review of 35 studies published between 1992 and 2017 regarding women's knowledge about mammography found that there is a great deal of confusion regarding the age and frequency with which mammography should be performed, with a very strong underestimation [33]. This serious confusion was also confirmed in our study. Although in Italy mammography is indicated in women over 40 and is offered free of charge by the National Health System (NHS) to women over 50 and up to 69 years of age, there are still very few women who are aware of it and, even stranger, only 4% of Group A and, incredibly, no woman with previous cancer considered it advisable to perform this examination in the 50-69 range, the only period covered by free screening. This figure indicates a strong gap regarding knowledge of the guidelines provided and probably, lack of adherence to the screening offered by the NHS in the specific age range. Coupled with this confusion is also an indecision regarding the frequency with which mammography is recommended. The Ministry of Health recommends mammography for women between the ages of 50 and 69, every two years [34], although some regions are testing the effectiveness of mammography in a wider age range [7,35,36] On the other hand, it is not recommended under the age of 40, as many of the women in the general population have felt.
Similarly to mammography, clinical palpation and ultrasound are also perceived as useful screening tests by the majority of women in both groups. Although ultrasonography is not generally recommended as a screening test in place of or in addition to mammography and MRI, CT, and blood tests are not screening tools but are recommended for possible post-diagnosis follow-up [37], many women in both groups considered the usefulness of these tests in the screening setting. The oncologist is also the reference figure in the case of established diagnosis, but is still perceived as supporting prevention. In the remaining part of the questionnaire, knowledge toward breast self-diagnosis was investigated. Breast palpation is recommended as early as age 20 and can be performed by clinical examination or breast self-examination and allows each woman to get to know her breast and appreciate any changes that might occur in the interval between one examination and the next [38]. Incredibly, only 1% of women in both groups strongly agree about its preventive role, with even a high percentage of women strongly disagreeing about its usefulness in prevention. This is an important finding that again suggests to us the need for further appropriate educational and informational interventions; indeed, it is likely that a knowledge gap exists about breast cancer risk and in subsequent screening and prevention recommendations [39,40]. The results of the study must be considered taking into account some limitations. The reference sample consisted mainly of young women under 30 years of age, and only 338 women (14%) were in the 50-69 age group, potentially leading to an underestimation of this demographic segment. This limitation is surely related to the mode of administration through the telematic medium, which is probably more used by younger women. Another limitation mainly concerns the choice of electronic dissemination of the questionnaire that may have partially excluded those who had little computer background. Possible information bias may be due to a reluctant attitude to declare and therefore admit a lack of knowledge of the phenomenon.

Conclusions

The results obtained, in the literature, demonstrate a lack of knowledge regarding each section provided in the questionnaire, confirming previous studies In fact, a great deal of confusion has emerged about both the symptomatology and causes associated with cancer, but also about prevention, and this confusion is present especially among women in the general population and women with low levels of education. The great misinformation about cancer and the risk factors and symptomatology associated with it highlight an important need to provide women with more information to ensure better knowledge on the topic. There is definitely a need for better dissemination and implementation regarding the benefits of preventive practices, based on evidence, in order to increase women's confidence in prevention pathways and consequently ensure as early a diagnosis as possible. In fact, on the subject of prevention, it should be considered that despite the fact that nowadays there is greater awareness and better management of screening programs, the number of women adhering to them is still small. Low participation in screening [41], in fact, can be attributed to low public awareness and/or numerous social, psychological barriers and social factors. Knowing the risk factors associated with cancer is also an important means for all those women who have no signs and symptoms of disease. Therefore, it is essential to promote awareness of risk factors and increased participation in mammography practice in women of screening age. Therefore, it would be appropriate to increase the information possessed by these women and screening adherence campaigns, making use of the centers specialized in the early diagnosis and treatment of breast cancer, such as the Breast Units in the territory. There are at least 200 Breast Units and, according to the State-Regions Conference [42], they prove to be useful not only in the case of patients with cancer, but also in the case of healthy women without family history for whom it is useful to ensure prevention and early diagnosis, encouraging correct lifestyles and doing training activities, allowing breast examinations through which, if necessary, diagnostic tests can be accessed. In light of these data, it therefore remains of utmost importance to promote correct health information on the subject of risk factors, symptomatology and prevention associated with this terrible disease, which is still a major cause of suffering and premature mortality in women worldwide.

Author Contributions

Study conception and design: RL, LC, MC, GDN; data collection RL, LC, SB, MC, RM, AL, EV, IR, MC, MM and FG; analysis and interpretation: LC; manuscript writing: LC, RL, EV, GDN, MF; approval of the final article: all authors; accountability for all aspects of the work: all authors.

Funding

The authors received no financial support for the research.

Conflict Of Interest

Authors declare no conflict of interest.

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA. Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed]
  2. Amuta, A.O.; Mkuu, R.S.; Jacobs, W.; Ejembi, A.Z. Influence of Cancer Worry on Four Cancer Related Health Protective Behaviors among a Nationally Representative Sample: Implications for Health Promotion Efforts. J. Cancer Educ. 2018, 33, 1002–1010. [Google Scholar] [CrossRef] [PubMed]
  3. AIOM-AIRTUM-Siapec-Iap I Numeri Del Cancro in Italia 2022. Available online: https://www.aiom.it/wp-content/uploads/2022/12/2022_AIOM_NDC-web.pdf (accessed on 10 October 2023).
  4. Petrelli, A.; Di Napoli, A.; Sebastiani, G.; Rossi, A.; Giorgi Rossi, P.; Demuru, E.; Costa, G.; Zengarini, N.; Alicandro, G.; Marchetti, S.; et al. Italian Atlas of Mortality Inequalities by Education Level. Epidemiol. Prev. 2019, 43, 1–120. [Google Scholar] [CrossRef] [PubMed]
  5. Petrelli, A.; Giorgi Rossi, P.; Francovich, L.; Giordani, B.; Di Napoli, A.; Zappa, M.; Mirisola, C.; Gargiulo, L. Geographical and Socioeconomic Differences in Uptake of Pap Test and Mammography in Italy: Results from the National Health Interview Survey. BMJ Open 2018, 8, e021653. [Google Scholar] [CrossRef]
  6. Wegwarth, O.; Widschwendter, M.; Cibula, D.; Sundström, K.; Portuesi, R.; Lein, I.; Rebitschek, F.G. What Do European Women Know about Their Female Cancer Risks and Cancer Screening? A Cross-Sectional Online Intervention Survey in Five European Countries. BMJ Open 2018, 8, e023789. [Google Scholar] [CrossRef]
  7. Conte, L.; De Nunzio, G.; Lupo, R.; Mieli, M.; Lezzi, A.; Vitale, E.; Carriero, M.C.; Calabrò, A.; Carvello, M.; Rubbi, I.; et al. Breast Cancer Prevention: The Key Role of Population Screening, Breast Self-Examination (BSE) and Technological Tools. Survey of Italian Women. J. Cancer Educ. 2023, 38, 1728–1742. [Google Scholar] [CrossRef]
  8. Cheng, I.; Tseng, C.; Wu, J.; Yang, J.; Conroy, S.M.; Shariff-Marco, S.; Li, L.; Hertz, A.; Gomez, S.L.; Le Marchand, L.; et al. Association between Ambient Air Pollution and Breast Cancer Risk: The Multiethnic Cohort Study. Int. J. Cancer 2020, 146, 699–711. [Google Scholar] [CrossRef]
  9. Chiriac, V.-F.; Baban, A.; Dumitrascu, D.L. Psychological Stress and Breast Cancer Incidence: A Systematic Review. Clujul Med. 2018, 91, 18–26. [Google Scholar] [CrossRef]
  10. Kim, S.; Ko, Y.; Lee, H.J.; Lim, J.-E. Menopausal Hormone Therapy and the Risk of Breast Cancer by Histological Type and Race: A Meta-Analysis of Randomized Controlled Trials and Cohort Studies. Breast Cancer Res. Treat. 2018, 170, 667–675. [Google Scholar] [CrossRef]
  11. Yuan, X.; Yi, F.; Hou, C.; Lee, H.; Zhong, X.; Tao, P.; Li, H.; Xu, Z.; Li, J. Induced Abortion, Birth Control Methods, and Breast Cancer Risk: A Case-Control Study in China. J. Epidemiol. 2019, 29, 173–179. [Google Scholar] [CrossRef]
  12. Fitzpatrick, D.; Pirie, K.; Reeves, G.; Green, J.; Beral, V. Combined and Progestagen-Only Hormonal Contraceptives and Breast Cancer Risk: A UK Nested Case-Control Study and Meta-Analysis. PLoS Med. 2023, 20, e1004188. [Google Scholar] [CrossRef] [PubMed]
  13. Qiu, R.; Zhong, Y.; Hu, M.; Wu, B. Breastfeeding and Reduced Risk of Breast Cancer: A Systematic Review and Meta-Analysis. Comput. Math. Methods Med. 2022, 2022, 8500910. [Google Scholar] [CrossRef] [PubMed]
  14. Zuzak, T.Z.; Hałgas, M.; Kowalska, K.; Gospodarczyk, M.; Wdowiak-Filip, A.; Filip, M.; Zuzak, Z.; Kowaluk, G.; Wdowiak, A. Breast Cancer – the Level of Knowledge about Epidemiology and Prophylaxis among Polish Medical Universities Students. Eur. J. Med. Technol. 2018, 1, 29–34. [Google Scholar]
  15. Picon-Ruiz, M.; Morata-Tarifa, C.; Valle-Goffin, J.J.; Friedman, E.R.; Slingerland, J.M. Obesity and Adverse Breast Cancer Risk and Outcome: Mechanistic Insights and Strategies for Intervention. CA. Cancer J. Clin. 2017, 67, 378–397. [Google Scholar] [CrossRef] [PubMed]
  16. Cortesi, L.; Galli, G.R.; Domati, F.; Conte, L.; Manca, L.; Berio, M.A.; Toss, A.; Iannone, A.; Federico, M. Obesity in Postmenopausal Breast Cancer Patients: It Is Time to Improve Actions for a Healthier Lifestyle. The Results of a Comparison Between Two Italian Regions With Different “Presumed” Lifestyles. Front. Oncol. 2021, 11. [Google Scholar] [CrossRef]
  17. Aureli, V.; Rossi, L. Nutrition Knowledge as a Driver of Adherence to the Mediterranean Diet in Italy. Front. Nutr. 2022, 9, 804865. [Google Scholar] [CrossRef]
  18. González-Palacios Torres, C.; Barrios-Rodríguez, R.; Muñoz-Bravo, C.; Toledo, E.; Dierssen, T.; Jiménez-Moleón, J.J. Mediterranean Diet and Risk of Breast Cancer: An Umbrella Review. Clin. Nutr. 2023, 42, 600–608. [Google Scholar] [CrossRef]
  19. Kamińska, M.; Ciszewski, T.; Łopacka-Szatan, K.; Miotła, P.; Starosławska, E. Breast Cancer Risk Factors. Menopausal Rev. 2015, 3, 196–202. [Google Scholar] [CrossRef]
  20. Conte, L.; Lupo, R.; Lezzi, A.; Paolo, V.; Rubbi, I.; Rizzo, E.; Carvello, M.; Calabrò, A.; Botti, S.; De Matteis, E.; et al. A Nationwide Cross-Sectional Study Investigating Adherence to the Mediterranean Diet, Smoking, Alcohol and Work Habits, Hormonal Dynamics between Breast Cancer Cases and Healthy Subjects. Clin. Nutr. Open Sci. 2024. [Google Scholar] [CrossRef]
  21. Tafuri, B.; Conte, L.; Portaluri, M.; Galiano, A.; Maggiulli, E.; De Nunzio, G. Radiomics for the Discrimination of Infiltrative vs In Situ Breast Cancer. Biomed. J. Sci. Tech. Res. 2019, 24. [Google Scholar] [CrossRef]
  22. Conte, L.; Tafuri, B.; Portaluri, M.; Galiano, A.; Maggiulli, E.; De Nunzio, G. Breast Cancer Mass Detection in DCE–MRI Using Deep-Learning Features Followed by Discrimination of Infiltrative vs. In Situ Carcinoma through a Machine-Learning Approach. Appl. Sci. 2020, 10, 6109. [Google Scholar] [CrossRef]
  23. Conte, L.; Rizzo, E.; Grassi, T.; Bagordo, F.; De Matteis, E.; De Nunzio, G. Artificial Intelligence Techniques and Pedigree Charts in Oncogenetics: Towards an Experimental Multioutput Software System for Digitization and Risk Prediction. Computation 2024, 12, 47. [Google Scholar] [CrossRef]
  24. Conte, L.; Lupo, R.; Sciolti, S.; Lezzi, A.; Rubbi, I.; Botti, S.; Carvello, M.; Fanizzi, A.; Massafra, R.; Vitale, E.; et al. Exploring the Landscape of Breast Cancer Prevention among Chinese Residents in Italy: An In-Depth Analysis of Screening Adherence, Breast Self-Examination (BSE) Practices, the Role of Technological Tools, and Misconceptions Surrounding Risk Factors and Sy. Int. J. Environ. Res. Public Health 2024, 21, 308. [Google Scholar] [CrossRef]
  25. Conte, L.; Lupo, R.; Lezzi, A.; Sciolti, S.; Rubbi, I.; Carvello, M.; Calabrò, A.; Botti, S.; Fanizzi, A.; Massafra, R.; et al. Breast Cancer Prevention Practices and Knowledge in Italian and Chinese Women in Italy: Clinical Checkups, Free NHS Screening Adherence, and Breast Self-Examination (BSE). J. Cancer Educ. 2024. [Google Scholar] [CrossRef]
  26. Conte, L.; De Nunzio, G.; Lupo, R.; Mieli, M.; Lezzi, A.; Vitale, E.; Carriero, M.C.; Calabrò, A.; Carvello, M.; Rubbi, I.; et al. Breast Cancer Prevention: The Key Role of Population Screening, Breast Self-Examination (BSE) and Technological Tools. Survey of Italian Women. J. Cancer Educ. 2023. [Google Scholar] [CrossRef] [PubMed]
  27. De Cicco, P.; Catani, M.V.; Gasperi, V.; Sibilano, M.; Quaglietta, M.; Savini, I. Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence. Nutrients 2019, 11. [Google Scholar] [CrossRef] [PubMed]
  28. Li, L.; Li, S.; Qin, S.; Gao, Y.; Wang, C.; Du, J.; Zhang, N.; Chen, Y.; Han, Z.; Yu, Y.; et al. Diet, Sports, and Psychological Stress as Modulators of Breast Cancer Risk: Focus on OPRM1 Methylation. Front. Nutr. 2021, 8, 747964. [Google Scholar] [CrossRef]
  29. Youn, H.J.; Han, W. A Review of the Epidemiology of Breast Cancer in Asia: Focus on Risk Factors. Asian Pac. J. Cancer Prev. 2020, 21, 867–880. [Google Scholar] [CrossRef] [PubMed]
  30. Reményi Kissné, D.; Gede, N.; Szakács, Z.; Kiss, I. Breast Cancer Screening Knowledge among Hungarian Women: A Cross-Sectional Study. BMC Womens. Health 2021, 21, 69. [Google Scholar] [CrossRef]
  31. Rahman, S.A.; Al-Marzouki, A.; Otim, M.; Khalil Khayat, N.E.H.; Yousuf, R.; Rahman, P. Awareness about Breast Cancer and Breast Self-Examination among Female Students at the University of Sharjah: A Cross-Sectional Study. Asian Pac. J. Cancer Prev. 2019, 20, 1901–1908. [Google Scholar] [CrossRef]
  32. Al-Mousa, D.S.; Alakhras, M.; Hossain, S.Z.; Al-Sa’di, A.G.; Al Hasan, M.; Al-Hayek, Y.; Brennan, P.C. Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women. Breast cancer (Dove Med. Press. 2020, 12, 231–242. [Google Scholar] [CrossRef]
  33. Seaman, K.; Dzidic, P.L.; Castell, E.; Saunders, C.; Breen, L.J. A Systematic Review of Women’s Knowledge of Screening Mammography. The Breast 2018, 42, 81–93. [Google Scholar] [CrossRef] [PubMed]
  34. Italian Ministery of Health Screening Oncologici Available online:. Available online: https://www.salute.gov.it/portale/donna/dettaglioContenutiDonna.jsp?id=4511&area=Salute+donna&menu=prevenzione (accessed on 24 July 2022).
  35. Ugai, T.; Sasamoto, N.; Lee, H.-Y.; Ando, M.; Song, M.; Tamimi, R.M.; Kawachi, I.; Campbell, P.T.; Giovannucci, E.L.; Weiderpass, E.; et al. Is Early-Onset Cancer an Emerging Global Epidemic? Current Evidence and Future Implications. Nat. Rev. Clin. Oncol. 2022, 19, 656–673. [Google Scholar] [CrossRef]
  36. Badrinarayanan, V.; Kendall, A.; Cipolla, R. SegNet: A Deep Convolutional Encoder-Decoder Architecture for Image Segmentation. IEEE Trans. Pattern Anal. Mach. Intell. 2017, 39, 2481–2495. [Google Scholar] [CrossRef] [PubMed]
  37. Sun, Y.-S.; Zhao, Z.; Yang, Z.-N.; Xu, F.; Lu, H.-J.; Zhu, Z.-Y.; Shi, W.; Jiang, J.; Yao, P.-P.; Zhu, H.-P. Risk Factors and Preventions of Breast Cancer. Int. J. Biol. Sci. 2017, 13, 1387–1397. [Google Scholar] [CrossRef]
  38. Budh, D.P.; Sapra, A. Breast Cancer Screening; 2022;
  39. Rainey, L.; van der Waal, D.; Jervaeus, A.; Donnelly, L.S.; Evans, D.G.; Hammarström, M.; Hall, P.; Wengström, Y.; Broeders, M.J.M. European Women’s Perceptions of the Implementation and Organisation of Risk-Based Breast Cancer Screening and Prevention: A Qualitative Study. BMC Cancer 2020, 20, 247. [Google Scholar] [CrossRef] [PubMed]
  40. Rainey, L.; Jervaeus, A.; Donnelly, L.S.; Evans, D.G.; Hammarström, M.; Hall, P.; Wengström, Y.; Broeders, M.J.M.; Waal, D. Women’s Perceptions of Personalized Risk-based Breast Cancer Screening and Prevention: An International Focus Group Study. Psychooncology. 2019, 28, 1056–1062. [Google Scholar] [CrossRef] [PubMed]
  41. Al-Naggar, R.A.; Bobryshev, Y. V; Al-Jashamy, K. Practice of Breast Self-Examination among Women in Malaysia. Asian Pac. J. Cancer Prev. 2012, 13, 3829–3833. [Google Scholar] [CrossRef] [PubMed]
  42. Mazzocco, K.; Masiero, M.; Carriero, M.C.; Pravettoni, G. The Role of Emotions in Cancer Patients’ Decision-Making. Ecancermedicalscience 2019, 13. [Google Scholar] [CrossRef]
Figure 1. Flow diagram for questionnaire participants’ selection.
Figure 1. Flow diagram for questionnaire participants’ selection.
Preprints 116177 g001
Table 1. Baseline characteristics and the questionnaire items of all respondents. Section 2 of the Questionnaire is related to screening adhesion for all women.
Table 1. Baseline characteristics and the questionnaire items of all respondents. Section 2 of the Questionnaire is related to screening adhesion for all women.

Baseline characteristics

N
(= 2375)

%
Age (y)
20-29 1076 45
30-39 544 23
40-49 417 18
50-59 249 10
60-69 89 4
Geographic Area
North 607 26
Center 512 22
South/Islands 1256 53
Marital status
Married 944 40
Divorced 81 3
Maiden 1280 54
Separate 46 2
Widow 24 1
Education level
Degree 954 40
High school graduation 1197 50
Junior high school diploma 202 9
Primary school 17 1
None 5 <1
Employment status
Craftsman 254 11
Public Administration 624 26
Services/Tertiary 356 15
Student 746 31
Retired 50 2
Unemployed 345 15
Table 2. Questionnaire responses of the adult female population among subjects who had not been diagnosed with breast cancer (Group A, n=2235) and subjects who had already been diagnosed with breast cancer (Group B, n=140). Differences in response between the two Groups were assessed. A p value <0.05 was considered statistically significant (*p<0.05; **p<0.01; ***p<0.001).
Table 2. Questionnaire responses of the adult female population among subjects who had not been diagnosed with breast cancer (Group A, n=2235) and subjects who had already been diagnosed with breast cancer (Group B, n=140). Differences in response between the two Groups were assessed. A p value <0.05 was considered statistically significant (*p<0.05; **p<0.01; ***p<0.001).

Questionnaire items
Group A
Women in the general population
(n=2235) N (%)
Group B
Women with cancer

(n=140) N (%)

p-value

SECTION 1: Knowledge and beliefs about the causes and symptomatology of breast cancer
Q1. Do you think you are well informed about breast cancer?
Very
Quite
Little
Not at all


132 (6%)
1118 (50%)
898 (40%)
87 (4%)


52 (37%)
79 (56%)
9 (6%)
0


<0.05*
Q2. Do you think the cause of breast cancer is endocrine?
No
Yes


372 (17%)
1863 (83%)


40 (29%)
100 (71%)


<0.001***
Q3. Do you think a cause of breast cancer may be previous breast disease?
No
Yes


122 (5%)
2213 (95%)


17 (12%)
123 (88%)


<0.01**
Q4. Do you think a cause of breast cancer may be food?
No
Yes


1136 (51%)
1099 (49%)


46 (33%)
94 (67%)


<0.001***
Q5. Do you think a cause of breast cancer may be environmental factors and pollution?
No
Yes


553 (25%)
1682 (75%)


27 (19%)
113 (81%)


0.15
Q6. Do you think a cause of breast cancer may be psychological stress?
No
Yes


1153 (52%)
1082 (48%)


41 (29%)
99 (71%)


0.01**
Q7. Do you think breast pain may be a symptom of cancer?
No
Yes
I don't know.


836 (37%)
1319 (59%)
80 (4%)


93 (66%)
46 (33%)
1 (1%)


0.19
Q8. Do you think the presence of a palpable nodule may be a symptom of the tumor?
No
Yes
I don't know.



713 (32%)
1452 (65%)
70 (3%)



23 (16%)
116 (83%)
1 (1%)



0.19
Q9. Do you think that the change in breast shape and size may be a symptom of cancer?
No
Yes
I don't know



565 (25%)
1579 (71%)
91 (4%)



38 (27%)
100 (71%)
2 (1%)


<0.05*
Q10. Do you think nipple discharge may be a symptom of the tumor?
No
Yes
I don't know.


29 (38%)
45 (59%)
2 (3%)


39 (28%)
99 (71%)
2 (1%)


0.19
Q11. Do you think that nipple alteration may be a symptom of the tumor?
No
Yes
I don't know.


597 (27%)
1548 (69%)
90 (4%)


39 (28%)
99 (71%)
2 (1%)


0.19


SECTION2: Knowledge and beliefs about breast cancer prevention
Q12. Do you think you are well informed about breast cancer prevention?
A lot
Quite
Little
Not at all


123 (6%)
1062 (48%)
914 (41%)
136 (6%)


43 (31%)
82 (59%)
12 (9%)
3 (2%)



<0.05*
Q13. What does prevention mean to you?
Carry out periodic checks
Prevention of risk factors and early diagnosis Prevention of complications
I don't know.

20 (1%)
2110 (94%)
80 (4%)
25 (1%)

0
128 (91%)
11 (8%)
1 (1%)

0.20
Q14. If I found a lump, would treatment be more effective?
Strongly agree
Agreed
In disagreement
Strongly disagree
Uncertain


670 (30%)
920 (41%)
94 (4%)
18 (1%)
533 (24%)


64 (46%)
45 (302%)
3 (2%)
1 (1%)
27 (19%)


<0.05*
Q15. Do you consider mammography useful as an act of breast cancer prevention?
No
Yes



26 (1%)
2209 (99%)



3 (2%)
137 (98%)



0.15
Q16. What does mammography mean to you?
Breast self-examination and self-palpation Ultrasound
Oncologist's physical examination Radiological examination of the breast I don't know.


28 (1%)
1 (0%)
110 (5%)
2075 (93%)
21 (1%)


0
0
1 (1%)
139 (99%)
21 (1%)


0.103
Q17. At what age do you think mammography is recommended?
<20 years old
20-30
30-40
40-50
50-60
60-70
I don't know.


37 (2%)
479 (21%)
833 (37%)
786 (35%)
80 (4%)
2 (0%)
18 (1%)


3 (2%)
27 (19%)
65 (46%)
44 (31%)
0
0
1 (1%)


0.05*
Q18. How often do you think mammography is recommended?
Based on age/familiarity
More than once a year
Once a year
Every two years
I don't know.


7 (0%)
317 (14%)
1581 (71%)
316 (14%)
14 (1%)


2 (1%)
11 (8%)
108 (77%)
19 (14%)
0


0.15
Q19. Do you consider clinical palpation useful as an act of breast cancer prevention?
No
Yes



131 (6%)
2104 (94%)



10 (7%)
130 (93%)



0.15
Q20. Do you think bilateral ultrasound is useful as an act of breast cancer prevention?
No
Yes



226 (10%)
2009 (90%)



7 (5%)
133 (95%)



<0.05*
Q21. Do you think Nuclear Magnetic Resonance Imaging (MRI) is useful as an act of breast cancer prevention?
No
Yes



295 (80%)
76 (20%)



1650 (74%)
585 (26%)



0.15
Q22. Do you consider biopsy useful as an act of breast cancer prevention?
No
Yes


1501 (67%)
734 (33%)


97 (69%)
43 (31%)


0.15
Q23. Do you think Computed Tomography (CT) is useful as an act of breast cancer prevention?
No
Yes



1699 (76%)
536 (24%)



111 (79%)
29 (21%)



0.15
Q24. Do you consider blood tests useful as an act of breast cancer prevention?
No
Yes


1063 (48%)
1172 (52%)


92 (66%)
48 (34%)


<0.001***
Q25. Do you consider the interview with the oncologist useful as an act of breast cancer prevention?
No
Yes



1226 (55%)
1009 (45%)



92 (66%)
48 (34%)



<0.01**
Q26. Have you ever heard of self-examination?
No
Yes


65 (3%)
2170 (97%)


3 (2%)
137 (98%)


0.66
Q27. In your opinion, what does self-examination consist of?
Breast self-examination
Clinical examination of the breast (search for visible and/or palpatory findings at the breast and surrounding areas, e.g., lymphatic drainage areas axilla, neck) Breast radiological examination (mammography, ultrasound, MRI, biopsy, chest X-ray, scintigraphy, CT scan, PET/CT, chest X-ray)
I don't know.


1840 (82%)


337 (15%)

24 (1%)



34 (2%)


122 (87%)


17 (12%)

0



1 (1%)


0.11
Q28. Does self-examination help in breast cancer prevention?
Strongly agree
Agreed
In disagreement
Strongly disagree
Uncertain


21 (1%)
122 (5%)
1054 (47%)
535 (24%)
503 (12%)


1 (1%)
11 (8%)
60 (43%)
43 (31%)
25 (18%)


<0.05*
Q29. Is self-palpation not necessary if I perform a breast examination?
Strongly agree
Agreed
In disagreement
Strongly disagree
Uncertain


2189 (98%)
46 (2%)
0
0


136 (97%)
4 (3%)
0
0


0.53
Q30. Is self-palpation not necessary if I perform periodic mammography?
Strongly agree
Agreed
In disagreement
Strongly disagree
Uncertain


19 (1%)
143 (6%)
1067 (48%)
492 (22%)
514 (23%)


2 (1%)
7 (5%)
64 (46%)
41 (29%)
26 (19%)


<0.05*
Q31. Performing self-examination decreases mortality.
Strongly agree
Agreed
In disagreement
Strongly disagree
Uncertain


547 (24%)
807 (36%)
154 (7%)
32 (1%)
695 (31%)


42 (30%)
51 (36%)
15 (11%)
0
32 (23%)


<0.05*
Q32. Performing self-examination once a month helps me find lumps
Strongly agree
Agreed
In disagreement
Strongly disagree
Uncertain


978 (44%)
1001 (45%)
242 (11%)
13 (1%)
1 (0%)


65 (46%)
56 (40%)
16 (11%)
2 (1%)
1 (1%)


0.33
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

© 2024 MDPI (Basel, Switzerland) unless otherwise stated